ABHD6 and fatty liver disease: Antisense oligonucleotide (ASO)-mediated knock down of ABHD6 in murine liver and white adipose tissue of mice protected them from HFD-induced obesity, hepatic steatosis, and insulin resistance [8], suggesting a role of ABHD6 in the pathogenesis of metabolic syndrome.